CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aya Fukuizumi, MD, Rintaro Noro, MD, PhD, Masahiro Seike, MD, PhD, Akihiko Miyanaga, MD, PhD, Yuji Minegishi, MD, PhD, Miwako Omori, MD, Mamiko Hirao, Kuniko Matsuda, Shinobu Kunugi, MD, PhD, Kazutaka Nishiwaki, Masahiro Morimoto, Haruka Motohashi, Hayato Ohwada, PhD, Jitsuo Usuda, MD, PhD, Akihiko Gemma, MD, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/790906db2fa7483283e2b97f1365bd03
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:790906db2fa7483283e2b97f1365bd03
record_format dspace
spelling oai:doaj.org-article:790906db2fa7483283e2b97f1365bd032021-12-02T05:03:45ZCADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis2666-364310.1016/j.jtocrr.2021.100232https://doaj.org/article/790906db2fa7483283e2b97f1365bd032021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666364321000916https://doaj.org/toc/2666-3643Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10 non–IPF-LC) by whole-exome sequencing and bioinformatics analysis and established a medical-engineering collaboration with the Department of Engineering of the Tokyo University of Science. Results: In IPF-LC, CADM1 and SPC25 were mutated at a frequency of 47% (9 of 19) and 53% (10 of 19), respectively. Approximately one-third of the IPF-LC cases (7 of 19; 36%) had both mutations. Pathway analysis revealed that these two genes are involved in transforming growth factor-β1 signaling. CADM1 and SPC25 gene mutations decreased the expression of CADM1 and increased that of SPC25 revealing transforming growth factor-β1–induced epithelial-to-mesenchymal transition and cell proliferation in lung cancer cells. Furthermore, treatment with paclitaxel and DNMT1 inhibitor suppressed SPC25 expression. Conclusions: CADM1 and SPC25 gene mutations may be novel diagnostic markers and therapeutic targets for IPF-LC.Aya Fukuizumi, MDRintaro Noro, MD, PhDMasahiro Seike, MD, PhDAkihiko Miyanaga, MD, PhDYuji Minegishi, MD, PhDMiwako Omori, MDMamiko HiraoKuniko MatsudaShinobu Kunugi, MD, PhDKazutaka NishiwakiMasahiro MorimotoHaruka MotohashiHayato Ohwada, PhDJitsuo Usuda, MD, PhDAkihiko Gemma, MD, PhDElsevierarticleCADM1SPC25Whole-exome sequencingLung cancerIdiopathic pulmonary fibrosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100232- (2021)
institution DOAJ
collection DOAJ
language EN
topic CADM1
SPC25
Whole-exome sequencing
Lung cancer
Idiopathic pulmonary fibrosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle CADM1
SPC25
Whole-exome sequencing
Lung cancer
Idiopathic pulmonary fibrosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Aya Fukuizumi, MD
Rintaro Noro, MD, PhD
Masahiro Seike, MD, PhD
Akihiko Miyanaga, MD, PhD
Yuji Minegishi, MD, PhD
Miwako Omori, MD
Mamiko Hirao
Kuniko Matsuda
Shinobu Kunugi, MD, PhD
Kazutaka Nishiwaki
Masahiro Morimoto
Haruka Motohashi
Hayato Ohwada, PhD
Jitsuo Usuda, MD, PhD
Akihiko Gemma, MD, PhD
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
description Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10 non–IPF-LC) by whole-exome sequencing and bioinformatics analysis and established a medical-engineering collaboration with the Department of Engineering of the Tokyo University of Science. Results: In IPF-LC, CADM1 and SPC25 were mutated at a frequency of 47% (9 of 19) and 53% (10 of 19), respectively. Approximately one-third of the IPF-LC cases (7 of 19; 36%) had both mutations. Pathway analysis revealed that these two genes are involved in transforming growth factor-β1 signaling. CADM1 and SPC25 gene mutations decreased the expression of CADM1 and increased that of SPC25 revealing transforming growth factor-β1–induced epithelial-to-mesenchymal transition and cell proliferation in lung cancer cells. Furthermore, treatment with paclitaxel and DNMT1 inhibitor suppressed SPC25 expression. Conclusions: CADM1 and SPC25 gene mutations may be novel diagnostic markers and therapeutic targets for IPF-LC.
format article
author Aya Fukuizumi, MD
Rintaro Noro, MD, PhD
Masahiro Seike, MD, PhD
Akihiko Miyanaga, MD, PhD
Yuji Minegishi, MD, PhD
Miwako Omori, MD
Mamiko Hirao
Kuniko Matsuda
Shinobu Kunugi, MD, PhD
Kazutaka Nishiwaki
Masahiro Morimoto
Haruka Motohashi
Hayato Ohwada, PhD
Jitsuo Usuda, MD, PhD
Akihiko Gemma, MD, PhD
author_facet Aya Fukuizumi, MD
Rintaro Noro, MD, PhD
Masahiro Seike, MD, PhD
Akihiko Miyanaga, MD, PhD
Yuji Minegishi, MD, PhD
Miwako Omori, MD
Mamiko Hirao
Kuniko Matsuda
Shinobu Kunugi, MD, PhD
Kazutaka Nishiwaki
Masahiro Morimoto
Haruka Motohashi
Hayato Ohwada, PhD
Jitsuo Usuda, MD, PhD
Akihiko Gemma, MD, PhD
author_sort Aya Fukuizumi, MD
title CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
title_short CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
title_full CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
title_fullStr CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
title_full_unstemmed CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
title_sort cadm1 and spc25 gene mutations in lung cancer patients with idiopathic pulmonary fibrosis
publisher Elsevier
publishDate 2021
url https://doaj.org/article/790906db2fa7483283e2b97f1365bd03
work_keys_str_mv AT ayafukuizumimd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT rintaronoromdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT masahiroseikemdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT akihikomiyanagamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT yujiminegishimdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT miwakoomorimd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT mamikohirao cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT kunikomatsuda cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT shinobukunugimdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT kazutakanishiwaki cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT masahiromorimoto cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT harukamotohashi cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT hayatoohwadaphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT jitsuousudamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
AT akihikogemmamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis
_version_ 1718400658937217024